Seth M. Klein

784 total citations
7 papers, 685 citations indexed

About

Seth M. Klein is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Seth M. Klein has authored 7 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Surgery and 2 papers in Oncology. Recurrent topics in Seth M. Klein's work include Cholesterol and Lipid Metabolism (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Seth M. Klein is often cited by papers focused on Cholesterol and Lipid Metabolism (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Seth M. Klein collaborates with scholars based in United States and New Zealand. Seth M. Klein's co-authors include Margery A. Connelly, David L. Williams, Margarita de la Llera-Moya, George H. Rothblat, Patricia G. Yancey, Nada A. Abumrad, Salman Azhar, Pascale Monzo, William J. Johnson and Snehasikta Swarnakar and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Journal of Hepatology.

In The Last Decade

Seth M. Klein

7 papers receiving 679 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seth M. Klein United States 6 455 355 212 173 132 7 685
Catherine L. Knapper United States 9 576 1.3× 413 1.2× 150 0.7× 316 1.8× 118 0.9× 10 795
Horng-Yuan Kan United States 14 426 0.9× 330 0.9× 255 1.2× 110 0.6× 83 0.6× 17 622
Kristin L. Gillotte United States 10 454 1.0× 398 1.1× 205 1.0× 119 0.7× 108 0.8× 11 887
F.H. Mahlberg United States 8 392 0.9× 306 0.9× 159 0.8× 58 0.3× 121 0.9× 8 620
Florence H. Mahlberg United States 6 337 0.7× 207 0.6× 131 0.6× 62 0.4× 103 0.8× 7 511
Mehrdad Haghpassand United States 12 832 1.8× 588 1.7× 244 1.2× 374 2.2× 229 1.7× 14 1.1k
Stefan Jäckle Germany 18 237 0.5× 471 1.3× 137 0.6× 79 0.5× 122 0.9× 26 752
E M Rubin United States 6 556 1.2× 370 1.0× 325 1.5× 60 0.3× 203 1.5× 6 943
Baukje M. Elzinga Netherlands 8 372 0.8× 317 0.9× 83 0.4× 231 1.3× 92 0.7× 11 671
H Czarnecka Canada 8 285 0.6× 134 0.4× 197 0.9× 80 0.5× 88 0.7× 11 455

Countries citing papers authored by Seth M. Klein

Since Specialization
Citations

This map shows the geographic impact of Seth M. Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth M. Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth M. Klein more than expected).

Fields of papers citing papers by Seth M. Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seth M. Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth M. Klein. The network helps show where Seth M. Klein may publish in the future.

Co-authorship network of co-authors of Seth M. Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Seth M. Klein. A scholar is included among the top collaborators of Seth M. Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seth M. Klein. Seth M. Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Klein, Seth M., et al.. (2016). The Multikinase Inhibitor Regorafenib Improves Portal Hypertension in Presence and Absence of Cirrhosis in Rats. Journal of Hepatology. 64(2). S134–S135. 3 indexed citations
2.
Parathath, Saj, Margery A. Connelly, Robert Rieger, et al.. (2004). Changes in Plasma Membrane Properties and Phosphatidylcholine Subspecies of Insect Sf9 Cells Due to Expression of Scavenger Receptor Class B, Type I, and CD36. Journal of Biological Chemistry. 279(40). 41310–41318. 41 indexed citations
3.
Klein, Seth M., et al.. (2001). Two Forms of Mitochondrial DNA Ligase III Are Produced inXenopus laevis Oocytes. Journal of Biological Chemistry. 276(52). 48978–48987. 21 indexed citations
4.
Connelly, Margery A., Margarita de la Llera-Moya, Pascale Monzo, et al.. (2001). Analysis of Chimeric Receptors Shows That Multiple Distinct Functional Activities of Scavenger Receptor, Class B, Type I (SR-BI), Are Localized to the Extracellular Receptor Domain. Biochemistry. 40(17). 5249–5259. 70 indexed citations
5.
Llera-Moya, Margarita de la, Margery A. Connelly, Seth M. Klein, et al.. (2001). Scavenger receptor class B type I affects cholesterol homeostasis by magnifying cholesterol flux between cells and HDL. Journal of Lipid Research. 42(12). 1969–1978. 95 indexed citations
6.
Yancey, Patricia G., Margarita de la Llera-Moya, Snehasikta Swarnakar, et al.. (2000). High Density Lipoprotein Phospholipid Composition Is a Major Determinant of the Bi-directional Flux and Net Movement of Cellular Free Cholesterol Mediated by Scavenger Receptor BI. Journal of Biological Chemistry. 275(47). 36596–36604. 265 indexed citations
7.
Connelly, Margery A., Seth M. Klein, Salman Azhar, Nada A. Abumrad, & David L. Williams. (1999). Comparison of Class B Scavenger Receptors, CD36 and Scavenger Receptor BI (SR-BI), Shows That Both Receptors Mediate High Density Lipoprotein-Cholesteryl Ester Selective Uptake but SR-BI Exhibits a Unique Enhancement of Cholesteryl Ester Uptake. Journal of Biological Chemistry. 274(1). 41–47. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026